We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Collagen Solutions Plc | LSE:COS | London | Ordinary Share | GB00B94T6Y14 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 6.625 | 6.25 | 7.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMCOS
RNS Number : 4331Q
Collagen Solutions PLC
12 September 2017
12 September 2017
Collagen Solutions Plc
(the "Company" or "Collagen Solutions")
Issue of Equity
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that it has allotted, in aggregate, 217,475 new ordinary shares of 1p each in the Company ("Ordinary Shares") to Orthomimetics Limited, in order to satisfy the final tranche of the deferred consideration share provisions in relation to the ChondroMimetic assets acquisition, as announced on 14 September 2015.
Application has been made for the 217,475 new Ordinary Shares to be admitted to trading on AIM ("Admission"), which is expected to occur at 8.00 a.m. on or around 15 September 2017. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares. Following Admission, and for the purposes of the FCA's Disclosure Guidance and Transparency Rules, the Company's total issued share capital will consist of 324,516,552 Ordinary Shares. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the issued share capital of the Company.
Enquiries:
Hot Features
Premium
Collagen Solutions Plc
Jamal Rushdy, CEO Mob: +1 612 405 7709
Gill Black, CFO Tel: 0141 648 9100
Cenkos Securites Plc (Nominated
Advisor and Broker)
Stephen Keys Tel: 020 7397 8900
Steven Cox
Walbrook PR Ltd Tel: 020 7933 8780 or
collagen@walbrookpr.com
Anna Dunphy Mob: 07876 741 001
Mike Wort Mob: 07900 608 002
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEUAURRBNAKAUR
(END) Dow Jones Newswires
September 12, 2017 02:01 ET (06:01 GMT)
1 Year Collagen Solutions Chart |
1 Month Collagen Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
